Dr. Mengyang Di is a lymphoma/CLL clinician and assistant professor at University of Washington/Fred Hutch Cancer Center. She completed her internal medicine residency training at Brown University and her hematology/oncology fellowship at Yale University. She is interested in examining novel therapies or new combinations of drugs for lymphoma in clinical trials. Her research has also been focused on assessing lymphoma outcomes in real-world practice, identifying challenges (e.g., factors on the practice- or policy-level) contributing to suboptimal outcomes, and eventually designing interventions to improve care quality and outcomes.